NSHS — Nanosphere Health Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.21m
- CA$0.19m
Annual cashflow statement for Nanosphere Health Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.51 | -3.47 | -0.591 | -0.356 | -0.282 |
| Depreciation | |||||
| Non-Cash Items | 0.916 | 1.59 | 0.092 | -0.037 | 0.053 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.316 | 0.662 | 0.438 | 0.328 | 0.161 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.24 | -1.08 | -0.047 | -0.065 | -0.068 |
| Capital Expenditures | -0.302 | -0.053 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.2 | -0.329 | 0 | — | — |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.5 | -0.382 | 0 | — | — |
| Financing Cash Flow Items | -0.017 | -0.041 | 0 | -0.008 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.29 | 1.28 | 0.034 | 0.182 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.49 | -0.178 | -0.021 | 0.118 | -0.076 |